account_balance
Investment manager · 13F filer · SEC CIK 1425738
Redmile Group, LLC
Reported value$1.49Bas of Jun 30, 2026
Positions39 4 new, 0 sold out
Top 10 weight73%SRRK alone is 16%
FiledAug 1445 days after quarter end
Portfolio · as of Jun 30, 2026
Where the money is
New or addedTrimmedHeld
SRRK
Scholar Rock Hldg Corp
15.9%Trimmed
KRYS
Krystal Biotech INC
15.8%Trimmed
STOK
Stoke Therapeutics INC
8.7%Trimmed
IMNM
Immunome INC
7.0%Trimmed
NRIX
Nurix Therapeutics INC
6.6%Trimmed
ABSI
Absci Corporation
5.2%Trimmed
ANNX
Annexon INC
4.6%Trimmed
RGNX
Regenxbio INC
3.5%
STTK
Shattuck Labs INC
3.2%Added
NGNE
Neurogene INC
3.0%Trimmed
29 others
26.5%
Box size is the share of the fund's reported holdings. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.
What changed